版本:
中国

BRIEF-Horizon Pharma says unit enters into settlement deal with Express Scripts - SEC filing

Sept 29 Horizon Pharma PLC :

* On Sept 26, Horizon Pharma USA entered settlement agreement and mutual release with Express Scripts to settle litigation - SEC filing

* 25 percent of settlement amount will be paid to Express Scripts in Q1 of 2017 and 25 percent in Q2 of 2017

* Horizon Pharma's discussions with Express Scripts regarding DUEXIS and VIMOVO on its formulary exclusion list are ongoing

* Settlement amount will be paid to Express Scripts in installments, with 50 percent of installment paid in Q4 of 2016

* Expects that settlement payment will be recorded as a reduction in GAAP net sales in Q3 of fiscal 2016

* Continues its discussions and negotiations with other pharmacy benefit managers and payers Source text bit.ly/2dgJGYB Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐